Teva Pharmaceutical Industries (TEVA) Tax Rate (2009 - 2026)
Teva Pharmaceutical Industries' (TEVA) quarterly Tax Rate came in at 26.59% in Q2 2026, up 1183.0% on a YoY basis from 2.07% in Q2 2025, and down 273.45% quarter-over-quarter from 15.33% in Q1 2026.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Tax Rate (2009 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has reported Tax Rate for 18 consecutive years, with 26.59% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Rate rose 1183.0% year-over-year to 26.59%; the trailing twelve-month figure through Jun 2026 stood at 1.69% (up 12737.0% YoY), and the FY2025 full-year result was 14.72%, up 3793.0% from the prior year.
- Tax Rate eased to 26.59% in Q2 2026 per TEVA's latest filing, from 15.33% in the prior quarter.
- Across five years, Tax Rate topped out at 76.4% in Q2 2022 and bottomed at 487.5% in Q4 2025.
- Historically, Tax Rate has averaged 36.36% across 5 years, with a median of 5.67% in 2022.
- The widest YoY moves for Tax Rate: up 21767 bps in 2025, down 47616 bps in 2025.
- Over 5 years, Tax Rate stood at 12.57% in 2022, then surged by 164 bps to 8.09% in 2023, then sank by 240 bps to 11.34% in 2024, then slumped by 4200 bps to 487.5% in 2025, then jumped by 95 bps to 26.59% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 26.59%, 15.33%, and 487.5% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.76 Bn | 39.10 Bn | 2.15 Bn | -26.59% |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | -85.63% |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 21.32% |
| 4 | Amneal Pharmaceuticals | 5.52 Bn | 5.39 Bn | 334.51 Mn | 1.94% |
| 5 | Bausch Health Companies | 2.38 Bn | 545.13 Mn | 2.10 Bn | 25.29% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 0.09% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 33.43% |
| 8 | Amphastar Pharmaceuticals | 992.46 Mn | 702.34 Mn | 93.47 Mn | 21.26% |
| 9 | Fennec Pharmaceuticals | 409.53 Mn | 368.28 Mn | 17.15 Mn | 2.08% |
| 10 | RedHill Biopharma | 179.80 Mn | 179.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.59% |
| Mar 31, 2026 | 15.33% |
| Dec 31, 2025 | -487.50% |
| Sep 30, 2025 | 33.13% |
| Jun 30, 2025 | -38.42% |
| Mar 31, 2025 | 25.17% |
| Dec 31, 2024 | -11.34% |
| Sep 30, 2024 | -21.30% |
| Jun 30, 2024 | -256.10% |
| Mar 31, 2024 | -11.13% |
| Dec 31, 2023 | 8.09% |
| Sep 30, 2023 | -18.75% |
| Jun 30, 2023 | 1.73% |
| Mar 31, 2023 | 6.99% |
| Dec 31, 2022 | -12.57% |
| Sep 30, 2022 | 62.57% |
| Jun 30, 2022 | 76.40% |
| Mar 31, 2022 | -0.21% |
| Dec 31, 2021 | 13.71% |
| Sep 30, 2021 | 19.90% |